Financial report interval: 2026.03.30 - 2026.06.30
Overview: CANSINOBIO(06185) the Revenue is 411.3 M (+40.19%), Beat estimate;the EBIT is 71.41 M (+2541%), Beat estimate;the EPS is 0.185 (--%), Miss estimate.